These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32592956)

  • 1. Gene expression analysis of activating and inhibitory receptors of natural killer cells in patients with acute myeloblastic leukemia.
    Ghasemimehr N; Moazed V; Fatemi A
    Adv Med Sci; 2020 Sep; 65(2):354-360. PubMed ID: 32592956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia.
    Sandoval-Borrego D; Moreno-Lafont MC; Vazquez-Sanchez EA; Gutierrez-Hoya A; López-Santiago R; Montiel-Cervantes LA; Ramírez-Saldaña M; Vela-Ojeda J
    Arch Med Res; 2016 Jan; 47(1):55-64. PubMed ID: 26876298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The studies for activating and inhibitory receptors on natural killer cells in HIV/HCV co-infected patients].
    Zhao P; Zhang X; Kang FB; Zhang XW; Zhang L; Tan WH; Chen WW; Zhao M
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Jun; 25(3):182-4. PubMed ID: 21977586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of NKG2A with treatment for chronic hepatitis C virus infection.
    Harrison RJ; Ettorre A; Little AM; Khakoo SI
    Clin Exp Immunol; 2010 Aug; 161(2):306-14. PubMed ID: 20550548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Balance between activating NKG2D, DNAM-1, NKp44 and NKp46 and inhibitory CD94/NKG2A receptors determine natural killer degranulation towards rheumatoid arthritis synovial fibroblasts.
    Nielsen N; Pascal V; Fasth AE; Sundström Y; Galsgaard ED; Ahern D; Andersen M; Baslund B; Bartels EM; Bliddal H; Feldmann M; Malmström V; Berg L; Spee P; Söderström K
    Immunology; 2014 Aug; 142(4):581-93. PubMed ID: 24673109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequency and role of NKp46 and NKG2A in hepatitis B virus infection.
    Yoshioka T; Tatsumi T; Miyagi T; Mukai K; Nishio K; Nishio A; Yokoyama Y; Suda T; Kegasawa T; Shigekawa M; Hikita H; Sakamori R; Takehara T
    PLoS One; 2017; 12(3):e0174103. PubMed ID: 28328926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKG2A Down-Regulation by Dasatinib Enhances Natural Killer Cytotoxicity and Accelerates Effective Treatment Responses in Patients With Chronic Myeloid Leukemia.
    Chang MC; Cheng HI; Hsu K; Hsu YN; Kao CW; Chang YF; Lim KH; Chen CG
    Front Immunol; 2018; 9():3152. PubMed ID: 30705677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of activating natural killer-cell receptors is a hallmark of the innate-like T-cell neoplasm in peripheral T-cell lymphomas.
    Uemura Y; Isobe Y; Uchida A; Asano J; Nishio Y; Sakai H; Hoshikawa M; Takagi M; Nakamura N; Miura I
    Cancer Sci; 2018 Apr; 109(4):1254-1262. PubMed ID: 29363227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer.
    Han B; Mao FY; Zhao YL; Lv YP; Teng YS; Duan M; Chen W; Cheng P; Wang TT; Liang ZY; Zhang JY; Liu YG; Guo G; Zou QM; Zhuang Y; Peng LS
    J Immunol Res; 2018; 2018():6248590. PubMed ID: 30255106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Surface Receptor Expression and Cytotoxicity of Human NK Cells and NK Cell Subsets in Overweight and Obese Humans.
    Naujoks W; Quandt D; Hauffe A; Kielstein H; Bähr I; Spielmann J
    Front Immunol; 2020; 11():573200. PubMed ID: 33101297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of in vitro IL-2 or IL-15 alone or in combination with Hsp-70-derived 14-mer peptide (TKD) on the expression of NK cell activatory and inhibitory receptors.
    Hromadnikova I; Pirkova P; Sedlackova L
    Mediators Inflamm; 2013; 2013():405295. PubMed ID: 23476104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the Expression of Surface Receptors on NK Cells and NKG2D on Immunocytes in Peripheral Blood of Patients with Nasopharyngeal Carcinoma.
    Xu Y; Zhou R; Huang C; Zhang M; Li J; Zong J; Qiu S; Lin S; Chen H; Ye Y; Pan J
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):661-665. PubMed ID: 29580037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of NKG2A inhibitory receptor on circulating NK cells contributes to transfusion-induced immunodepression in patients with β-thalassemia major.
    Zou Y; Song ZX; Lu Y; Liang XL; Yuan Q; Liao SH; Bao JJ
    J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):509-513. PubMed ID: 27465324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.
    Fauriat C; Just-Landi S; Mallet F; Arnoulet C; Sainty D; Olive D; Costello RT
    Blood; 2007 Jan; 109(1):323-30. PubMed ID: 16940427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced Expression of Natural Killer Cell-Related Activating Receptors by Peripheral Blood Mononuclear Cells from Patients with Breast Cancer and Their Improvement by Zoledronic Acid.
    Rahimian L; Kalantari Khandani B; Nemati M; Hoseini-Shahrestanak S; Aminizadeh N; Jafarzadeh A
    Asian Pac J Cancer Prev; 2022 May; 23(5):1661-1669. PubMed ID: 35633551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HBsAg stimulates NKG2D receptor expression on natural killer cells and inhibits hepatitis C virus replication.
    Wang XX; Pan XB; Han JC; Cong X; Jin Q; Kong XS; Wei L; Feng B
    Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):233-240. PubMed ID: 29625837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients.
    Mirjačić Martinović KM; Babović NLj; Džodić RR; Jurišić VB; Tanić NT; Konjević GM
    Melanoma Res; 2014 Aug; 24(4):295-304. PubMed ID: 24769842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune checkpoint molecule DNAM-1/CD112 axis is a novel target for natural killer-cell therapy in acute myeloid leukemia.
    Kaito Y; Sugimoto E; Nakamura F; Tsukune Y; Sasaki M; Yui S; Yamaguchi H; Goyama S; Nannya Y; Mitani K; Tamura H; Imai Y
    Haematologica; 2024 Apr; 109(4):1107-1120. PubMed ID: 37731380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of NK cells dysfunction in multiple myeloma patients].
    Han W; Zhang X; Jia Z; He J; Chao H; Yang J; Xiao R; Lu X
    Zhonghua Xue Ye Xue Za Zhi; 2015 Nov; 36(11):922-5. PubMed ID: 26632464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of NKp30, NKp46 and DNAM-1 activating receptors on resting and IL-2 activated NK cells from healthy donors according to CMV-serostatus and age.
    Campos C; López N; Pera A; Gordillo JJ; Hassouneh F; Tarazona R; Solana R
    Biogerontology; 2015 Oct; 16(5):671-83. PubMed ID: 25991472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.